Home » Topics » Immune, BioWorld Science

Immune, BioWorld Science
RSS

Twinrix approved for marketing in Canada

Sep. 25, 1997

NABI introduces new formulation of WinRho SDF

Sep. 23, 1997

CD45RB antibody available for licensing from RCT

Sep. 17, 1997

Thailand grants first approval for WF-10

Sep. 17, 1997

Meiji Milk introduces new hepatitis B vaccine

Sep. 17, 1997

Promising preliminary phase III results reported for Lyme disease vaccine

Sep. 16, 1997

MGH and BioTransplant report advances in xenotransplantation research

Sep. 16, 1997

In vitro and in vivo antibacterial activity of two herbal medicines

Sep. 12, 1997

BioFocus and RDW begin collaboration for T-cell enzyme inhibitors

Sep. 10, 1997

New orally active immunosuppressant for combination with ciclosporin

Sep. 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...